Publications

Title

Author

Year

Tuberculosis Immunoreactivity Surveillance in Malawi (Timasamala)-A protocol for a cross-sectional Mycobacterium tuberculosis immunoreactivity survey in Blantyre, Malawi.

RICKMAN, HM; Phiri, MD; Feasey, HR A; Mbale, H; Nliwasa, M; Semphere, R; Chagaluka, G; FIELDING, K; Mwandumba, HC; HORTON, KC; NIGHTINGALE, ES; Henrion, MY R; Mbendera, K; Mpunga, JA; CORBETT, EL; MacPherson, P;

2024

PloS one, (2024).19 5 10.1371/journal.pone.0291215.

Comparing patterns of recent and remote Mycobacterium tuberculosis infection determined using the QuantiFERON-TB Gold Plus assay in a high TB burden setting.

Amofa-Sekyi, M; SCHAAP, A; Mureithi, L; Kosloff, B; Cheeba, M; Kangololo, B; Vermaak, R; Paulsen, R; RUPEREZ, M; FLOYD, S; De Haas, P; Fidler, S; HAYES, R; AYLES, H; Shanaube, K; TREATS study team,;

2024

PLOS global public health, (2024).4 5 10.1371/journal.pgph.0003182.

Estimating the potential health and economic impacts of new tuberculosis vaccines under varying delivery strategies in Delhi and Gujarat, India: a modelling study.

CLARK, RA; Portnoy, A; Weerasuriya, CK; SUMNER, T; Bakker, R; Harris, RC; Rade, K; Mattoo, SK; Tumu, D; Menzies, NA; WHITE, RG;

2024

The Lancet regional health - Southeast Asia, (2024).31, 10.1016/j.lansea.2024.100424.

Enhanced Tuberculosis Diagnosis With Computer-aided Chest X-ray and Urine Lipoarabinomannan in Adults With HIV Admitted to Hospital (CASTLE Study): A Cluster Randomized Trial.

BURKE, RM; Nyirenda, SK; Mtenga, T; Twabi, HH; Joekes, E; Walker, NF; Nyirenda, R; Gupta-Wright, A; Nliwasa, M; FIELDING, K; MacPherson, P; CORBETT, EL;

2024

Clinical Infectious Diseases, (2024).80 5 10.1093/cid/ciae273.

Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosis.

Khan, MF; Ali, A; Rehman, HM; Noor Khan, S; Hammad, HM; Waseem, M; Wu, Y; CLARK, TG; Jabbar, A;

2024

Scientific reports, (2024).14 1 10.1038/s41598-024-61752-6.

Sputum culture reversion in longer treatments with bedaquiline, delamanid, and repurposed drugs for drug-resistant tuberculosis.

Kho, S; Seung, KJ; Huerga, H; Bastard, M; KHAN, PY; Mitnick, CD; Rich, ML; Islam, S; Zhizhilashvili, D; Yeghiazaryan, L; Nikolenko, EN; Zarli, K; Adnan, S; Salahuddin, N; Ahmed, S; Vargas, ZH R; Bekele, A; Shaimerdenova, A; Tamirat, M; Gelin, A; Vilbrun, SC; Hewison, C; Khan, U; Franke, M;

2024

Nature communications, (2024).15 1 10.1038/s41467-024-48077-8.

The Effect of HIV on the Association of Hyperglycaemia and Active Tuberculosis in Zambia, a Case-Control Study.

Bailey, SL; FLOYD, S; Cheeba-Lengwe, M; Maluzi, K; Chiwele-Kangololo, K; Kaluba-Milimo, D; Amofa-Sekyi, M; Yudkin, JS; Godfrey-Faussett, P; AYLES, H;

2024

Journal of epidemiology and global health, (2024).14 3 10.1007/s44197-024-00236-2.

A novel regulatory interplay between atypical B12 riboswitches and uORF translation in Mycobacterium tuberculosis.

KIPKORIR, T; Polgar, P; Barker, D; D'Halluin, A; Patel, Z; Arnvig, KB;

2024

Nucleic Acids Research (NAR), (2024).52 13 10.1093/nar/gkae338.

Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis.

James, LP; Klaassen, F; SWEENEY, S; Furin, J; Franke, MF; Yaesoubi, R; Chesov, D; Ciobanu, N; Codreanu, A; Crudu, V; Cohen, T; Menzies, NA;

2024

PLoS medicine, (2024).21 5 10.1371/journal.pmed.1004401.

Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization.

Shattock, AJ; JOHNSON, HC; Sim, SY; Carter, A; Lambach, P; Hutubessy, RC W; Thompson, KM; Badizadegan, K; Lambert, B; Ferrari, MJ; JIT, M; FU, H; Silal, SP; Hounsell, RA; WHITE, RG; Mosser, JF; Gaythorpe, KA M; Trotter, CL; Lindstrand, A; O'Brien, KL; Bar-Zeev, N;

2024

Lancet (London, England), (2024).403 10441 10.1016/S0140-6736(24)00850-X.